Revelation Pharma is a national network of 503A and 503B compounding pharmacies providing innovative, quality and personalized pharmaceutical products and services through “industry best” patient care and solutions for customers. The Company distributes pharmaceutical products to human (patients and physician offices) and veterinary (individual pet owners and veterinary clinics) markets nationwide. The Company’s geographic footprint includes 15+ locations with licenses and revenue produced in all 50 states. Revelation offers compounded pharmaceutical solutions across a wide variety of therapeutic classes, including allergy, anti-infective, hormone, urology, veterinary, anti-inflammatory, nutrition, men’s health, women’s health, ophthalmology, and more. Revelation’s medication delivery form expertise includes tablet, injection, topical, pellet, and oral. Revelation Pharma has executed 18 acquisitions.
Revelation Pharma continues to pursue add-on opportunities of 503A and 503B compounding pharmacies that expand its geographic footprint, therapeutic expertise, and/or physician referral and patient base.